CHERUVU PAVAN (Chief Executive Officer) received a stock award from SIO GENE THERAPIES INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/9/2021ACC: 0001636050-21-000098
DirectorOfficer· Chief Executive Officer
Since Apr 2019
-14.88K
Net shares
Net seller
$21.1K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
37.57K acquired · 52.45K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+37.57K
Price / share
—
Trade value
—
% of position
20.8%
12/8/2021
180.43K→217.99K
Common Stock
Direct
Shares
−14.88K
Price / share
$1.42
Trade value
$21.14K
% of position
6.8%
12/8/2021
217.99K→203.11K
Total
Net shares
+22.68K
Net value
-$21.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/8/2021 | A · Award | +37.57K | — | — | 20.8% | 180.43K | 217.99K |
| Common Stock Direct | 12/8/2021 | F · Tax Withholding | −14.88K | $1.42 | $21.14K | 6.8% | 217.99K | 203.11K |
| Total | +22.68K | -$21.14K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
37.57K shares
Shares
−37.57K
Strike price
Held after
75.13K
Exercisable
—
12/8/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock37.57K shares | 12/8/2021 | D · Disposition | −37.57K | — | 75.13K |